References WHO Cumulative number of confirmed human cases of avian flu WHO Strategic Action Plan for Pandemic Influenza 2006-2007 Disclaimer – This press release contains certain forward-looking statements Novartis Group Novartis Group companies through the use of can be identified ‘to ‘forward-looking terminology such as ‘may,”potential,”commitment,’or similar expressions , or by express or implied discussions ‘may ‘be possible regulatory approvals, future sales or the effectiveness of Focetria or other vaccines, or in terms of the potential successfulness of new and advanced manufacturing technology. Such forward-looking statements reflect management’s current views with respect to future events and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ with Focetria expressed at significantly different from any future sales, performance or achievements expressed or implied by such statements. There can be no guarantee that Focetria or any other vaccine approved for all indications in any market, or that any vaccines Focetria achieve any particular revenue, or that a market will develop for Focetria article . In particular, the expectations of Focetria and other vaccines is affected, inter alia, unexpected regulatory actions or delays or government regulation generally, unexpected clinical trial results, including additional analysis of existing clinical data and new clinical data; competition in general, the ability of Novartis to obtain or maintain patent or other proprietary intellectual property protection, increased government engaged pressures , and other risks and factors. In the current form Novartis AG 20 – F with the U.S. Securities and Exchange Commission Should one or or or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated adopted, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake to update forward-looking statements in this press release as a result of new information, future events or otherwise.
Novartis AG is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products patients patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leading positions in these areas. In 2006 the Group achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion in research and development investments Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in more than 140 countries around the world. A potential pandemic.e. Ation, please visit.
The US – Mexico twinning will draw on the strength of people such as Ms. Rueda, that are not afraid at add cast their votes to a rising choral breast cancer campaigners. Rueda is here with us , I do not you? Actual she’s not here? as it is. Being Through the partnership started in today, we to combine of new friends at this global movement. We empowering women the responsibility for their health. Taking We will see that the U.S. And Mexico explore composed that there helping two countries and the world.